Colgate-Palmolive (CL)
NYSEConsumer StaplesHousehold & Personal ProductsSnapshot 2026-09-15
$87.00-1.01%
Close 2026-09-15 · 1-day change
NYSEConsumer StaplesHousehold & Personal ProductsSnapshot 2026-09-15
Research Workspace
Put CL beside peers and holdings, graph the same metric, and keep your notes with the evidence.
Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
Household Products is in steady. Describes the industry's cycle state, not a call on this stock.
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
The reason to own it still holds.
View ThesisRevenue is growing steadily — about 5% over the past year.
View GrowthRanks among the strongest in its industry on quality — around the top 20%.
View QualityManagement screens strong on capital allocation, earnings delivery, margins, the balance sheet.
View ManagementExpectations look reasonable — what the market is pricing in sits in line with or below what analysts forecast.
View ValuationModerate volatility — typically moves about 1% a day.
View RiskHealthy across the board
Colgate-Palmolive's growth has to keep compounding to justify the price. The company aims for revenue growth of 2% to 6% in 2026. Revenue grew 4.9% year over year, and the last quarter beat expectations. It trades at 23× P/E versus a peer median of 16×. The price reflects less growth than we forecast. A risk is that the company could cut guidance after recently raising it. This read is provisional. Our read remains intact.
Trailing returns as of 2026-09-15. CL is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 21 analysts currently covering CL (as of Sep 2026).
Based on 6 Wall Street analysts offering 12-month price targets for CL in the last 4 months.
Continue this research
Compare CL with peers and holdings, graph the same reported metric, keep your questions beside the evidence, and return when the facts change.
Free account required to save the handoff. No credit card.
| Compare | Company | Living FV | P/E | Revenue % | Quality |
|---|---|---|---|---|---|
| CL Selected company | Graph | Compare | Trend | Review | |
| Peer Add a competitor | Graph | Compare | Trend | Review | |
| Holding Compare a holding | Graph | Compare | Trend | Review |
Selected metric trend
Quarterly · checked companies · value or % of revenue
A consensus fair price across 12 valuation methods, at three horizons. As of 2026-09-15. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Household Products — fair value, gap to price, and forward P/E.
Compare the value case
Put CL next to peers and holdings, compare Living FV and multiples, then graph the driver behind the difference.
Potential brand sale could impact growth strategy.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-09-15. EPS is implied from price ÷ P/E. Not investment advice.
Current $87.00
The last 12 months of price, then the range of analyst 12-month targets from today’s $87.00.
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Top 10% on quality vs scored peers
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
Advances: Implement Strategic Growth and Productivity Program
Portfolio reshaping aligns with strategic growth initiatives.
Advances: Implement Strategic Growth and Productivity Program
Portfolio reshaping aligns with strategic growth initiatives.
Potential divestiture could impact growth and market share.
Advances: Implement Strategic Growth and Productivity Program
Growth plan aligns with strategic objectives and market expectations.
Advances: Achieve Revenue Growth of 2% to 6% in 2026
Q2 strength supports revenue growth target for 2026.
Advances: Increase Advertising Investment to Support Growth
New leadership in marketing supports growth objectives.
Threatens: Achieve Revenue Growth of 2% to 6% in 2026
Brokerages caution on growth-margin trade-off affecting revenue outlook.
